Retension Pharmaceuticals, Inc. · NASDAQ:RTSN
Bisson Sabine converted 4,115 Retension Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 13, 2026 · Filed Oct 13, 2026
On Oct 13, 2026, Bisson Sabine (CHIEF OPERATING OFFICER) converted 4,115 Retension Pharmaceuticals, Inc. shares, leaving 4,115 shares. Filed Oct 13, 2026 (Form 4).
- Converted
- 4,115 shares
- Holding after
- 4,115 shares
- Trading plan
- No
- Role
- CHIEF OPERATING OFFICER
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 13, 2026 | Common Stock | Conversion | 1,611 | 1,611 | Direct | |
| Oct 13, 2026 | Common Stock | Conversion | 2,504 | 4,115 | Direct |
Source
Related
- Retension Pharmaceuticals, Inc.
- Bisson Sabine
- Retension Pharmaceuticals, Inc. shareholders
- Schedule 13G · Pvg Asset Management Corp · Oct 16, 2026
- Schedule 13G · B Group, Inc. · Oct 16, 2026
- Schedule 13G · Laurence W. Lytton · Oct 15, 2026
- Schedule 13D · Eric Keller · Oct 14, 2026
- Form 4 · Berendt Michael J · Oct 13, 2026